Open the latest COVID treatment guidelines for favipiravir, children under 18 – pregnant women can add LAAB as a drug – help people access

The Department of Medical Services, Ministry of Public Health (MoPH) issues guidelines for medical practice, diagnosis, treatment and prevention of infections in hospitals. Coronavirus Disease 2019 (COVID-19) Case for Doctors and Public Health Personnel The revised version dated 30 November 2022, with two main points: 1. Adaptation of antiretroviral drugs in adults and children according to different symptom groups 2. Adaptation of Antibodies Long-acting (LABB)

for adjusting the antiviral drug In the case of children under 18 with mild symptoms no pneumonia no risk factors Take care according to the symptoms. Favipiravir can be given for 5 days. In pregnant women, favipiravir can be used in the second and third trimester if indicated and the benefit outweighs the risks. The decisions are made with patients and relatives.

Although an increase in long-acting antibody (LABB) is recommended in patients aged 12 years and older and weighing 40 kg or more, the recommended LAAB dose is the same as for adults.

Reporters report that adding LAAB as a drug to treat COVID-19 will help people have more access to expensive medicines. The price of the drug is 29,000 baht per year.

By the way, you can read the full details here.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.